prevalence study of hiv antibodies in patients with non-hodgkin's lymphoma (nhl) in lagos, nigeria.

NLM AIDSLINE Prevalence study of HIV antibodies in patients with non-Hodgkin's lymphoma (NHL) in Lagos, Nigeria. Akinsete I; Akanmu AS; Analo HI; Njoku OS; Okany CC; Army Base Hospital,
December 30, 1998

Int Conf AIDS. 1998;12:1107 (abstract no. 60581). Unique Identifier : BACKGROUND: The incidence of NHL has been noted to be increasing by 2-3% per year in the last two decades. This has been aetiologically attributed to immunosuppression associated with HIV infection. We tested this association by comparing the seroprevalence of HIV antibodies in Patients with lymphoid malignancies (CLL and NAL) and healthy bolld donors. METHOD: Routine blood donors were recruited over a period of 3 months and patients with lymphoid malignancies were recruited over a period of 15 months. They were screened for HIV antibodies using an E1A technique. Positive specimens were confirmed by Western blot. RESULTS: A total of 406 donors were screened. 20 (4.9%) were positive for HIV-1. A total of 30 patients (20 with NHL and 10 with CLL) were screened.5 (25%) of NHL patients were positive for HIV-1, None of CLL patient was positive. HIV-1 is prevelent in NHL patients than in normal donor population in Lagos. (P less than 0.05, P = 0.0047). CONCLUSION: HIV induced immunosuppression may be the predominant aetiological factor responsible for the increasing incidence of NHL worldwide. MEETING ABSTRACTS Human HIV Antibodies/BLOOD/IMMUNOLOGY HIV Infections/BLOOD/COMPLICATIONS/EPIDEMIOLOGY/IMMUNOLOGY Lymphoma, AIDS-Related/BLOOD/EPIDEMIOLOGY/IMMUNOLOGY Lymphoma, Non-Hodgkin/BLOOD/COMPLICATIONS/EPIDEMIOLOGY/ IMMUNOLOGY Nigeria/EPIDEMIOLOGY Prevalence

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases Adopted Russian orphan triumphs over challenges 26th Annual Minnesota AIDS Walk - Sunday, May 19, Minnehaha Park 'Gap' for HIV vaccine efforts after latest setback AIDS science at 30: 'Cure' now part of lexicon ARIZONA: Routine Skin Testing Available Again at Tuberculosis Clinic Starting May 20 NORTH DAKOTA: Officials: 26 Tuberculosis Cases from Grand Forks Outbreak AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common 'Gap' for HIV vaccine efforts after latest setback AUSTRALIA: HIV Rates Triple in the Northern Territory in Just 12 Months ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV No time to lose in the search for an HIV vaccine Health group didn't disclose HIV tests, apologizes NEW JERSEY: Drug Company Donates Thousands to HIV/AIDS Orgs PENNSYLVANIA: Scientists Weaken HIV Infection in Immune Cells Using Synthetic Agents Danish researchers issue statement: "We are not on the brink of an HIV cure"
Information in this article was accurate in December 30, 1998. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.